Outpatient versus Inpatient Primary Cleft Lip and Palate Surgery: Analysis of Early Complications

医学 门诊手术 伤口裂开 腭成形术 门诊部 外科 裂开 并发症 牙科 回廊的 内科学
作者
Rami S. Kantar,Michael J. Cammarata,William J. Rifkin,Natalie M. Plana,J. Rodrigo Diaz‐Siso,Roberto L. Flores
出处
期刊:Plastic and Reconstructive Surgery [Lippincott Williams & Wilkins]
卷期号:141 (5): 697e-706e 被引量:33
标识
DOI:10.1097/prs.0000000000004293
摘要

Background: Fiscal constraints are driving shorter hospital lengths of stay. Outpatient primary cleft lip surgery has been shown to be safe, but outpatient primary cleft palate surgery remains controversial. This study evaluates outcomes following outpatient versus inpatient primary cleft lip and palate surgery. Methods: The American College of Surgeons National Surgical Quality Improvement Program Pediatric database was used to identify patients undergoing primary cleft lip and palate surgery between 2012 and 2015. Patient clinical factors and 30-day complications were compared for outpatient versus inpatient primary cleft lip and palate surgery. Univariate and multivariate analyses were performed. Results: Three thousand one hundred forty-two patients were included in the primary cleft lip surgery group and 4191 in the primary cleft palate surgery group. Patients in the cleft lip surgery group with structural pulmonary abnormalities had a significantly longer hospital length of stay (β, 4.94; p = 0.001). Patients undergoing outpatient surgery had a significantly higher risk of superficial (OR, 1.99; p = 0.01) and deep wound dehiscence (OR, 2.22; p = 0.01), and were at a significantly lower risk of reoperation (OR, 0.36; p = 0.04) and readmission (OR, 0.52; p = 0.02). Conclusions: Outpatient primary cleft lip surgery is safe and has a complication profile similar to that of inpatient surgery. Outpatient primary cleft palate surgery is common practice in many U.S. hospitals and has a significantly higher rate of wound complications, and lower rates of reoperation and readmission. In properly selected patients, outpatient palatoplasty can be performed safely. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, III.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
ABC_IR发布了新的文献求助10
2秒前
BK_发布了新的文献求助10
2秒前
李悟尔发布了新的文献求助30
4秒前
科研完成签到,获得积分10
5秒前
小二郎的应助被早睡早起采纳,获得10
9秒前
家的方向发布了新的文献求助10
11秒前
大模型的应助被猪猪侠采纳,获得10
11秒前
李悟尔完成签到,获得积分10
12秒前
13秒前
14秒前
zzh完成签到,获得积分10
14秒前
果果123的应助被Lbw采纳,获得100
15秒前
栋dd完成签到 ,获得积分10
15秒前
16秒前
ding的应助被zzh采纳,获得30
17秒前
ABC_IR完成签到,获得积分10
17秒前
19秒前
派大力发布了新的文献求助10
21秒前
25秒前
25秒前
柱子pillar发布了新的文献求助10
28秒前
29秒前
我是老大的应助被野性的念之采纳,获得10
29秒前
sky完成签到 ,获得积分10
29秒前
29秒前
归一然完成签到 ,获得积分10
30秒前
zhangli发布了新的文献求助10
31秒前
dans宇完成签到,获得积分10
32秒前
冷静远望发布了新的文献求助10
33秒前
领导范儿的应助被科研采纳,获得10
33秒前
ym发布了新的文献求助20
34秒前
wushuang完成签到 ,获得积分10
34秒前
34秒前
hezi完成签到,获得积分10
35秒前
星城浮轩完成签到 ,获得积分10
36秒前
充电宝的应助被WangSiwei采纳,获得10
36秒前
37秒前
Zerta发布了新的文献求助10
39秒前
Enigma_GEB的应助被韶华采纳,获得30
40秒前
c7发布了新的文献求助10
41秒前
高分求助中
(应助此贴封号)通过应助OA文献获取积分 10000
Rosenblum, Global Change Biology 800
Computational Chemical Reaction Engineering: Modeling, Simulation, and Design with MATLAB 600
Organizational Behavior 510
Management and the Arts 510
CLSI C56QG Examples of Hemolyzed, Icteric, and Lipemic/Turbid Samples Quick Guide 400
Encyclopedia of Geology 2nd Edition 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 计算机科学 工程类 纳米技术 内科学 物理 有机化学 化学工程 生物化学 复合材料 光电子学 细胞生物学 心理学 量子力学 催化作用 物理化学 电极
热门帖子
关注 科研通微信公众号,转发送积分 7805161
求助须知:如何正确求助?哪些是违规求助? 9338809
关于积分的说明 20493159
捐赠科研通 7397225
什么是DOI,文献DOI怎么找? 3327709
关于科研通互助平台的介绍 2474554
邀请新用户注册赠送积分活动 2345846